0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Preparation Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Blood Preparation Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Blood Preparation Market by Product Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010981
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Preparation Market grew from USD 45.32 billion in 2024 to USD 47.81 billion in 2025. It is expected to continue growing at a CAGR of 5.29%, reaching USD 61.77 billion by 2030.

Revolutionizing Blood Preparation: An In-Depth Exploration

Blood preparation has evolved from a simple transfusion process into a highly sophisticated and vital pillar of modern healthcare. The journey from donor collection to patient administration now involves advanced separation technologies, stringent safety protocols, and precision medicine approaches that ensure optimal outcomes for diverse clinical needs. As the demand for high-quality blood components intensifies, stakeholders across the supply chain-from bioprocessing equipment manufacturers to hospital transfusion services-must navigate an increasingly complex ecosystem shaped by regulatory stringency, technological breakthroughs, and shifting epidemiological patterns.

This executive summary lays the foundation for an in-depth exploration of the blood preparation landscape, spotlighting transformative forces and strategic imperatives. It introduces a structured framework for understanding key market segments, regional dynamics, and the competitive landscape, all while highlighting the ramifications of newly implemented United States tariffs in 2025. By synthesizing comprehensive qualitative and quantitative insights, this section positions decision-makers to harness emerging opportunities, mitigate operational risks, and guide product development roadmaps. The insights presented here will inform strategies to enhance supply chain resilience, optimize cost structures, and elevate patient safety standards in an era defined by rapid innovation and regulatory evolution.

Landmark Shifts Reshaping the Blood Preparation Ecosystem

The blood preparation industry is undergoing transformational shifts driven by cutting-edge technologies and evolving clinical paradigms. Pathogen reduction methods that deploy UV light or chemical treatments have become critical, significantly reducing transfusion-transmitted infection risks. Concurrently, digitalization of the blood supply chain-from donor recruitment platforms powered by artificial intelligence to real-time inventory management solutions-has enhanced traceability and responsiveness, ensuring that hospitals and clinics maintain optimal stock levels.

In parallel, precision medicine initiatives are reshaping demand profiles, with tailored component therapies emerging for patient-specific needs. Personalized transfusion protocols now account for immunohematological markers, necessitating sophisticated laboratory screening and bespoke storage conditions. At the same time, the integration of cloud-based data analytics has enabled predictive modeling of demand surges, particularly in trauma and oncology settings. Regulatory agencies worldwide are responding to these developments by tightening standards around quality assurance and extending guidelines for novel blood-derived products. As a result, manufacturers and distributors must adapt swiftly, aligning product portfolios with the expectations of safety, efficacy, and digital interoperability that define the next generation of blood services.

Evaluating the 2025 US Tariff Overhaul on Blood Product Supply

The introduction of revised United States tariffs in 2025 has created ripple effects across the global blood preparation supply chain. Import duties on key consumables such as reagent kits, disposable collection sets, and preservation solutions have driven up procurement costs for processing centers. Hospitals and transfusion services are now assessing cost-recovery mechanisms while negotiating long-term contracts with suppliers to mitigate budgetary pressures.

These tariffs extend to critical capital equipment used in apheresis and plasma fractionation, leading to extended payback periods and reconsideration of expansion timelines. The increased cost basis has prompted some market participants to explore strategic sourcing from markets unaffected by the new duties, while others are investing in domestic manufacturing partnerships to secure a stable supply of essential inputs. Moreover, enhanced compliance requirements associated with export licenses and tariff classification have introduced additional administrative burdens. As organizations recalibrate financial models, they face the dual challenge of maintaining competitive pricing for healthcare providers while safeguarding profit margins in an environment of elevated cross-border trade costs.

Unveiling Core Market Segments Driving Growth in Blood Preparation

The blood preparation market encompasses a diverse array of product types, each meeting distinct clinical requirements. Cryoprecipitate remains indispensable for fibrinogen replacement in surgical and trauma care, while plasma derivatives-spanning freeze-dried, fresh frozen, and solvent-detergent treated variants-offer tailored clotting factor therapies for hemophilia and coagulopathy management. Platelet concentrates, whether pooled from multiple donors or derived from single donors, support thrombocytopenia interventions in oncology and transplant settings. Meanwhile, red blood cell components-ranging from frozen units for rare blood types to irradiated, leukoreduced, and washed variants-address immunocompromised patients and neonatal transfusions.

Applications of these components bifurcate into surgical transfusions, where cardiovascular, orthopedic, transplant, and trauma care drive procedural fluid requirements, and therapeutic transfusions focused on anemia correction, management of hematological disorders, and supportive oncology treatments. End users span from high-throughput ambulatory surgical centers-both general and specialty facilities such as cardiac and orthopedic centers-to public and private blood banks engaged in donor recruitment and inventory management. Community and diagnostic clinics are leveraging simpler transfusion protocols for outpatient therapies, while hospitals across secondary, specialty, and tertiary care tiers demand integrated blood services aligned with complex clinical pathways. Understanding these segment intersections is crucial for tailoring product offerings and optimizing channel strategies in a market defined by heterogeneity.

Navigating Regional Dynamics Across Americas, EMEA, and Asia-Pacific

Regional landscapes in blood preparation reveal striking contrasts in donation infrastructure, regulatory frameworks, and technological adoption. In the Americas, mature donation programs and established reimbursement models support advanced component usage, from pathogen-inactivated platelets to automated apheresis processes. North American suppliers often spearhead innovation, benefiting from robust clinical trial networks and significant R&D investments.

Europe, the Middle East, and Africa present a mosaic of regulatory harmonization initiatives alongside legacy systems that vary in sophistication. Western European countries maintain stringent quality standards and centralized blood services, whereas emerging markets in the region prioritize capacity building and infrastructure upgrades. In the Middle East and Africa, donor recruitment challenges and cold chain logistics remain focal points for capacity expansion, driving partnerships with global technology providers.

Asia-Pacific dynamics are propelled by rapidly expanding healthcare access and government-led initiatives to boost voluntary blood donation. Leading markets in Japan, South Korea, and Australia are adopting advanced separation technologies, while Southeast Asian and South Asian countries focus on scaling up basic transfusion services. Across the region, digital donor management platforms and mobile collection units are reshaping how blood centers engage with communities and manage inventory fluctuations.

Competitive Landscape Spotlight on Leading Blood Preparation Innovators

Innovation and strategic positioning within the blood preparation industry are shaped by a cadre of global leaders and emerging challengers. Established manufacturers are bolstering their portfolios through targeted acquisitions of niche biotech firms specializing in pathogen reduction systems and plasma fractionation equipment. Technology companies are forging collaborations with academic research centers to co-develop next-generation separation and storage solutions that extend shelf life and enhance component stability.

Several large-scale plasma collectors are differentiating through vertical integration, from donor recruitment platforms to end-to-end processing facilities, ensuring consistency in quality and cost control. Diagnostic firms are leveraging their assay capabilities to introduce automated immunohematology workstations, streamlining blood typing and compatibility testing. At the same time, mid-sized enterprises are gaining traction with flexible manufacturing models, offering contract processing services and custom formulation of preservative solutions for specialized clinical indications. These competitive maneuvers underscore a broader trend toward convergence of technology, diagnostics, and therapeutics in the pursuit of safer, more efficient blood preparation workflows.

Strategic Imperatives for Industry Leaders in Blood Preparation

To thrive in a rapidly evolving blood preparation market, industry players must pursue strategic imperatives that bolster resilience and drive differentiation. Investment in advanced pathogen inactivation platforms and cold chain monitoring systems will not only enhance patient safety but also reduce regulatory risk. Diversifying supplier networks beyond regions affected by elevated tariffs can mitigate cost exposure and safeguard continuity of critical supplies.

Embracing digital transformation across the supply chain-from AI-driven donor recruitment to predictive analytics for inventory management-will enable organizations to anticipate demand fluctuations and optimize resource allocation. Engaging proactively with regulatory bodies to shape emerging guidelines on novel blood products and data interoperability standards can accelerate market entry and streamline approval pathways. Tailoring product offerings to regional clinical practices, such as developing freeze-dried plasma for austere environments or modular blood processing units for emerging markets, will unlock new growth corridors. Furthermore, cultivating strategic alliances with academic institutions and contract research organizations can expedite innovation pipelines and reinforce the value proposition to healthcare providers.

Rigorous Methodology Underpinning Our Market Research

The insights presented in this report are underpinned by a rigorous, multi-faceted research approach that combines in-depth secondary research with targeted primary validation. A comprehensive review of industry publications, regulatory filings, and trade databases established the foundational understanding of market drivers, technological advancements, and tariff frameworks. Global company reports, investor presentations, and patent filings were evaluated to map competitive positioning and innovation trajectories.

Primary research was conducted through structured interviews with a spectrum of stakeholders, including blood center administrators, medical directors, supply chain executives, and regulatory affairs specialists. These dialogues provided first-hand perspectives on operational challenges, procurement strategies, and adoption barriers. Data triangulation techniques were employed to reconcile quantitative findings with qualitative insights, ensuring consistency and reliability. Peer reviews by independent experts in transfusion medicine and biomedical engineering further validated the analysis, while meticulous editorial oversight guaranteed clarity, coherence, and adherence to quality standards throughout the report.

Charting the Path Forward: Key Takeaways and Industry Outlook

The evolving demands of healthcare systems and technological maturation continue to redefine the contours of blood preparation. As stakeholders navigate the complexities introduced by recalibrated trade policies, heightened safety expectations, and shifting clinical paradigms, a clear roadmap emerges: prioritize innovation, embrace digital integration, and maintain agile supply chains. The segmentation insights outlined here offer a granular understanding of product, application, and end-user nuances, enabling stakeholders to align portfolios with precise clinical needs.

Regional analyses highlight the imperative of customizing market entry strategies to local regulatory and infrastructural contexts. The competitive landscape underscores the value of strategic partnerships and technology convergence in driving differentiated offerings. By operationalizing the actionable recommendations, organizations can not only surmount current challenges but also position themselves at the forefront of next-generation blood services. In sum, this comprehensive review illuminates the opportunities and obstacles that will shape the future of blood preparation, equipping decision-makers with the foresight to lead with confidence.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Cryoprecipitate
    • Plasma
      • Freeze-Dried Plasma
      • Fresh Frozen Plasma
      • Solvent-Detergent Plasma
    • Platelets
      • Pooled Platelets
      • Single Donor Platelets
    • Red Blood Cells
      • Frozen Red Blood Cells
      • Irradiated Red Blood Cells
      • Leukoreduced Red Blood Cells
      • Washed Red Blood Cells
  • Application
    • Surgical Transfusion
      • Cardiovascular Surgeries
      • Orthopedic Surgeries
      • Transplant Surgeries
      • Trauma Care
    • Therapeutic Transfusion
      • Anemia Management
      • Hematological Disorders
      • Oncology Treatments
  • End User
    • Ambulatory Surgical Centers
      • General ASCs
      • Specialty ASCs
        • Cardiac Centers
        • General ASCs
        • Orthopedic Centers
    • Blood Banks
      • Private Banks
      • Public Banks
    • Clinics
      • Community Clinics
      • Diagnostic Clinics
    • Hospitals
      • Secondary Care
      • Specialty Hospitals
      • Tertiary Care
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Fresenius Kabi AG
  • Terumo Corporation
  • Grifols, S.A.
  • Haemonetics Corporation
  • Macopharma S.A.S.
  • Octapharma AG
  • Baxter International Inc.
  • CSL Limited
  • B. Braun Melsungen AG
  • Ortho Clinical Diagnostics Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Preparation Market, by Product Type
8.1. Introduction
8.2. Cryoprecipitate
8.3. Plasma
8.3.1. Freeze-Dried Plasma
8.3.2. Fresh Frozen Plasma
8.3.3. Solvent-Detergent Plasma
8.4. Platelets
8.4.1. Pooled Platelets
8.4.2. Single Donor Platelets
8.5. Red Blood Cells
8.5.1. Frozen Red Blood Cells
8.5.2. Irradiated Red Blood Cells
8.5.3. Leukoreduced Red Blood Cells
8.5.4. Washed Red Blood Cells
9. Blood Preparation Market, by Application
9.1. Introduction
9.2. Surgical Transfusion
9.2.1. Cardiovascular Surgeries
9.2.2. Orthopedic Surgeries
9.2.3. Transplant Surgeries
9.2.4. Trauma Care
9.3. Therapeutic Transfusion
9.3.1. Anemia Management
9.3.2. Hematological Disorders
9.3.3. Oncology Treatments
10. Blood Preparation Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. General ASCs
10.2.2. Specialty ASCs
10.2.2.1. Cardiac Centers
10.2.2.2. General ASCs
10.2.2.3. Orthopedic Centers
10.3. Blood Banks
10.3.1. Private Banks
10.3.2. Public Banks
10.4. Clinics
10.4.1. Community Clinics
10.4.2. Diagnostic Clinics
10.5. Hospitals
10.5.1. Secondary Care
10.5.2. Specialty Hospitals
10.5.3. Tertiary Care
11. Americas Blood Preparation Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Blood Preparation Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Blood Preparation Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Fresenius Kabi AG
14.3.2. Terumo Corporation
14.3.3. Grifols, S.A.
14.3.4. Haemonetics Corporation
14.3.5. Macopharma S.A.S.
14.3.6. Octapharma AG
14.3.7. Baxter International Inc.
14.3.8. CSL Limited
14.3.9. B. Braun Melsungen AG
14.3.10. Ortho Clinical Diagnostics Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BLOOD PREPARATION MARKET MULTI-CURRENCY
FIGURE 2. BLOOD PREPARATION MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD PREPARATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BLOOD PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BLOOD PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD PREPARATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZE-DRIED PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOLVENT-DETERGENT PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD PREPARATION MARKET SIZE, BY POOLED PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SINGLE DONOR PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FROZEN RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATED RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCED RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHED RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ORTHOPEDIC SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSPLANT SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRAUMA CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD PREPARATION MARKET SIZE, BY GENERAL ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD PREPARATION MARKET SIZE, BY GENERAL ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIVATE BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PUBLIC BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. CANADA BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 87. CANADA BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 88. CANADA BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 89. CANADA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CANADA BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 91. CANADA BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 92. CANADA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. CANADA BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 94. CANADA BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 95. CANADA BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 96. CANADA BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 97. CANADA BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. GERMANY BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. GERMANY BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 166. GERMANY BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. GERMANY BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 170. GERMANY BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 171. GERMANY BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. GERMANY BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 173. GERMANY BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 174. GERMANY BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 175. GERMANY BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 176. GERMANY BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. FRANCE BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 179. FRANCE BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. FRANCE BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 183. FRANCE BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 184. FRANCE BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. FRANCE BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 186. FRANCE BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 187. FRANCE BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 188. FRANCE BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 189. FRANCE BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 203. ITALY BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ITALY BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 205. ITALY BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 206. ITALY BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 207. ITALY BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. ITALY BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 209. ITALY BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 210. ITALY BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ITALY BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 212. ITALY BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 213. ITALY BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 214. ITALY BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 215. ITALY BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. SPAIN BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. SPAIN BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 218. SPAIN BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 219. SPAIN BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SPAIN BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 222. SPAIN BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 223. SPAIN BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SPAIN BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 225. SPAIN BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 226. SPAIN BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 227. SPAIN BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 228. SPAIN BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 268. DENMARK BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. DENMARK BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 270. DENMARK BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 271. DENMARK BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 272. DENMARK BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. DENMARK BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 274. DENMARK BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 275. DENMARK BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. DENMARK BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 277. DENMARK BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 278. DENMARK BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 279. DENMARK BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 280. DENMARK BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 294. QATAR BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. QATAR BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 296. QATAR BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 297. QATAR BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 298. QATAR BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. QATAR BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 300. QATAR BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 301. QATAR BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. QATAR BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 303. QATAR BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 304. QATAR BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 305. QATAR BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 306. QATAR BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 307. FINLAND BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. FINLAND BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 309. FINLAND BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 310. FINLAND BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 311. FINLAND BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. FINLAND BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 313. FINLAND BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 314. FINLAND BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. FINLAND BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 316. FINLAND BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 317. FINLAND BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 318. FINLAND BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 319. FINLAND BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA BLOOD PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA BLOOD PREPARATION MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA BLOOD PREPARATION MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA BLOOD PREPARATION MARKET SIZE, BY SURGICAL TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 339. NIGERIA BLOOD PREPARATION MARKET SIZE, BY THERAPEUTIC TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 340. NIGERIA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. NIGERIA BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 342. NIGERIA BLOOD PREPARATION MARKET SIZE, BY SPECIALTY ASCS, 2018-2030 (USD MILLION)
TABLE 343. NIGERIA BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 344. NIGERIA BLOOD PREPARATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 345. NIGERIA BLOOD PREPARATION MARKET S

Companies Mentioned

The companies profiled in this Blood Preparation market report include:
  • Fresenius Kabi AG
  • Terumo Corporation
  • Grifols, S.A.
  • Haemonetics Corporation
  • Macopharma S.A.S.
  • Octapharma AG
  • Baxter International Inc.
  • CSL Limited
  • B. Braun Melsungen AG
  • Ortho Clinical Diagnostics Inc.

Methodology

Methodology DOWNLOAD NOW

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 47.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 61.77 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Preparation - Global Strategic Business Report - Product Image

Blood Preparation - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
EUR$5,850USDGBP
Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2024-2032 - Product Image

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
EUR$2,999USDGBP
Blood Preparation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Blood Preparation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
EUR$4,500USDGBP
Blood Preparation Market Report 2025 - Product Image

Blood Preparation Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Blood Preparation Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Blood Preparation Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
EUR$4,111USDGBP

About the Blood Preparation Market

The Blood Preparation market within the context of Blood Banking is a specialized sector of the healthcare industry that focuses on the collection, processing, storage, and distribution of blood and blood products. Blood banks are responsible for collecting, testing, and processing donated blood, as well as providing blood products to hospitals and other healthcare facilities. Blood Preparation involves the preparation of blood components such as red blood cells, platelets, and plasma for transfusion. It also includes the production of therapeutic proteins and other biopharmaceuticals derived from blood. The Blood Preparation market is highly regulated, with stringent safety and quality standards in place to ensure the safety of blood products. The market is also subject to changing trends in healthcare, such as the increasing demand for blood products due to the aging population. Some companies in the Blood Preparation market include Grifols, CSL Behring, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more